Interventional Oncology (TheraSphere) Sales Associate ... Interventional Oncology Consultant at Boston Scientific. Pursuant to Va. Code § 2.2-4312 (2000), Boston Scientific is providing notification that the unlawful manufacture, sale, distribution, dispensation, possession, or use of a controlled substance or marijuana is prohibited in the workplace and that violations will result in disciplinary action . We choose collaborative innovation, enabling precision . Roaring '20s Boston Scientific 2020 NSM #oneteam Team West Coast IO . Interventional Radiology - Boston Scientific Position: Clinical Trial Manager, Interventional Oncology - Remote Job<br>Additional Locations:  Diversity - Innovation - Caring - Global Collaboration - Winning Spirit - Caring - High Performance<br><br>At Boston Scientific, we’ll give you the opportunity to harness all that’s within you by working in teams of diverse and high-performing employees, tackling some of the most . Report this profile . February 15, 2017 BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology . Insights on the Global $2.2 Billion Interventional ... Ludovic Lanco - Territory manager and Therapy developer ... Position: Clinical Trial Manager, Interventional Oncology - Remote Job<br>Additional Locations:  Diversity - Innovation - Caring - Global Collaboration - Winning Spirit - Caring - High Performance<br><br>At Boston Scientific, we’ll give you the opportunity to harness all that’s within you by working in teams of diverse and high-performing employees, tackling some of the most . Clinical Trial Manager, Interventional Oncology Job Boston Scientific Maple Grove, MN 2 months ago Be among the first 25 applicants Pair your MFA Authenticator with a new code by scanning the QR code below. Or download for desktop. BTG Interventional Oncology is a global leader in delivering innovative IO Ablation solutions. Interventional Oncology Consultant at Boston Scientific University of Minnesota - Carlson School of Management Beau Toskich (L) and Aiwu Ruth He. Pursuant to Va. Code § 2.2-4312 (2000), Boston Scientific is providing notification that the unlawful manufacture, sale, distribution, dispensation, possession, or use of a controlled substance or marijuana is prohibited in the workplace and that violations will result in disciplinary action . First as product developer at PS-Medtech in Amsterdam (The Netherlands) and since 2016 at Boston Scientific, having different clinical, sales and . Credit: Varian Medical Systems, Inc. MARLBOROUGH, Mass. Need Help? Interventional Oncology. The Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, and global specialist healthcare company BTG plc announce their 2017 Interventional Oncology / Immuno-Oncology research grant . Senior Account-Manager Interventional Oncology, Boston Scientific Region Köln/Bonn 305 Kontakte. Boston Scientific maintains a drug-free workplace. With the interventional oncology devices market expected to reach $760 million by 2023 in the U.S. alone, we expect Boston Scientific to capture a larger share of this market potential in the . February 15, 2017 BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology . Boston Scientific. 11.3.2 Boston Scientific Corporation Business Overview and Its Total Revenue. The interventional oncology market includes major Tier I and II suppliers like Medtronic (Ireland), Boston Scientific (US), BD (US), Terumo (Japan), Merit Medical (US), AngioDynamics (US), J&J (US . The scope is to promote company products through education of current & potential customers and implant within a defined region by providing clinical education for routine issues. President, Interventional Oncology at Boston Scientific Greater Ottawa Metropolitan Area 500+ connections. London, UK, 15 February 2017. The global interventional oncology devices market report highlights that the market was valued at $2,429.2 million in 2020 and is expected to reach $7,861.1 million by the end of 2030. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. The ICEfx Cryoablation System is the next generation of ablation systems with a compact design and interface that offers predictable, reliable cryoablation performance and seamless therapy delivery with the exceptional ease of technical operation. This is a highly visible and influential role, representing the HEMA function to all stakeholders within the IO business. Our best-in-class portfolio enables personalised interventional strategies - innovative solutions that are supported by robust evidence and unparalleled educational partnership. In the last reported quarter, the company's earnings per share of 40 . Pair your authenticator app. BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology worldwide, have . Pursuant to Va. Code 2.2-4312 (2000), Boston Scientific is providing notification that the unlawful manufacture, sale, distribution, dispensation, possession, or use of a controlled substance or marijuana is prohibited in the workplace and that violations will result in disciplinary action up . View these types of content across a variety of Interventional Radiology topics, including Critical Limb Ischemia (CLI) & Peripheral Chronic Total Occlusion (CTO), Embolotherapy, Imaging - Peripheral, Interventional Oncology, Pancreaticobiliary, Peripheral Artery Disease, Prostate Cancer, Pulmonary Embolism, Single-Use Imaging, Superficial Venous Insufficiency, Venous Disease. 11.3.3 Boston Scientific Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction Boston Scientific Corporation BSX is scheduled to report third-quarter 2021 results on Oct 27, before the opening bell.. BTG plc 5 years 11 months Field Sales Trainer BTG plc Jul 2017 - Present 4 years 1 month. Transaction to Expand Boston Scientific Interventional Oncology Portfolio with Drug-Eluting Microspheres and Spherical Embolics MARLBOROUGH, Mass. Boston Scientific Shares Healthcare News With (link): Healthcare Topics COVID-19 , Food and Drug Administration , Oncology , Cardiac Monitoring , Cardiology , Heart Disease , Interventional Oncology , Patient Monitoring , Pain Management , Biosensors Boston Scientific signs bead agreement with Varian. - A brief overview of the global market for interventional oncology (IO) as a technology-driven specialty towards cancer intervention . August 21, 2017 BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme . The Interventional Oncology/Immuno-Oncology research grant program was established in 2017 to fund initiatives that evaluate how interventional oncology therapies stimulate the immune system; combine loco-regional and immunotherapy approaches to improve clinical outcome; and improve the understanding of the underlying mechanisms that cause . From the best access and embolization devices to the best therapy devices, you'll have access to the latest devices for minimally invasive, complex interventional . The market . Dickinson and Co. (BD), Boston Scientific Corp . It is an image-guided, minimally-invasive technique conducted by trained experts. The global interventional oncology market should reach $3.1 billion by 2026 from $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026. CORP-530323-AA FEB 2018 CORP-650002-AC JAN 2021 19th August 2019. . As technological advances are made, previous limitations are being broken. We've progressed our technologies, to be less invasive and more patient-centric. , Nov. 10, 2015 / PRNewswire / -- Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio -based . Insights on the Global $2.2 Billion Interventional Oncology Market 2021-2026 - Featuring Boston Scientific, Johnson & Johnson and Medtronic Among Others - ResearchAndMarkets.com December 23, 2021 . Install an authentication app. The Senior Manager, HEMA for the Interventional Oncology franchise has responsibility for developing and leading global strategies to ensure successful market access and meaningful health economic and value propositions. Enter the verification code. Queen's University. View job description, responsibilities and qualifications. Galil Cryoablation by Boston Scientific. London, UK, 15 February 2017. Total grant funding available for investigators has been doubled. Penn Veterinary Supply, Inc. Nov 1998 - Mar 20001 year 5 months. The scope is to promote company products through education of current & potential customers and implant within a defined region by providing clinical education for routine issues. Interventional oncology devices report classifies global market by share, trend, and on the basis of product type, process, cancer type, and region | Interventional Oncology (IO) Devices Industry Most procedures are either outpatient or require an . Boston Scientific has announced the completion of its acquisition of BTG, pursuant to the previously announced scheme of arrangement. centered around our three key franchises: interventional oncology, drug-eluting technologies for peripheral artery . Press release - Market Intelligence Data - Embolization in Interventional Oncology Market 2021 Analysis by Global Manufacturers - Braile Biomedica, Boston Scientific, Covidien, Merit Medical . What Does the Future Hold for Interventional Oncology? 11.2.2 Boston Scientific Business Overview and Its Total Revenue. We take aim with the promising results of targeted treatments that hit cancer harder. Shameli Van Amstel Accountmanager Interventional Oncology bij Boston Scientific Zwolle, Overijssel, Nederland Meer dan 500 connecties The newly released results of a long-term study showed adding TheraSpheres to a . Transaction to Expand Boston Scientific Interventional Oncology Portfolio with Drug-Eluting Microspheres and Spherical Embolics MARLBOROUGH, Mass. See if you qualify! Interventional oncology, a subspecialty of interventional radiology, finds application in the diagnosis and treatment of cancer and cancer-related problems. 20192 Jahre 10 Monate. Boston Scientific transforms lives through innovative medical solutions that improve the health of patients. View our latest virtual symposia and webinars on interventional oncology topics. The Americas field based "Medical Science Liaison" (MSL) is responsible for supporting the safe and effective use of Boston Scientific Interventional Oncology therapies, communicating complex medical and scientific information to healthcare professionals and communicating field medical intelligence/insights to internal stakeholders. 2. Boston Scientific is committed to advancing the treatment of cancer and other complex interventional procedures worldwide. Boston Scientific seeks to consistently grow sales faster than average market revenue growth 1 for our . After 20 years as a humanitarian exemption device (HDE), the FDA grants TheraSphere pre-market approval, making TheraSphere the only Y-90 . Interventional Oncology. The Global Interventional Oncology Devices Market size was valued at USD 1.92 Billion in 2019 and is expected to reach USD 3.11 Billion by 2027 at a CAGR of 6.6%. Interventional Oncology Devices Market Report, Growth Forecast, Industry Statistics Till 2028 By Top Manufactures: Medtronic, Boston Scientific Corporation, Terumo Europe NV, Merit Medical Systems , Nov. 10, 2015 / PRNewswire / -- Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio -based . Boston Scientific is committed to advancing the treatment of cancer and other complex interventional procedures worldwide. BTG develops and commercialises products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty . Dieses Profil melden Berufserfahrung Boston Scientific 20 Jahre 1 Monat Senior Account Manager Interventional Oncology . ET comments Interventional Oncology. Boston Scientific closes acquisition of BTG. Join to Connect Boston Scientific. 5.1 Boston Scientific 5.1.1 Boston Scientific Profile 5.1.2 Boston Scientific Main Business 5.1.3 Boston Scientific Interventional Oncology Products, Services and Solutions 5.1.4 Boston Scientific Interventional Oncology Revenue (US$ Million) and (2016-2021) 5.1.5 Boston Scientific Recent Developments 5.2 BTG 5.2.1 BTG Profile 5.2.2 BTG Main . A collection of projections from interventional radiologists around the world. Boston Scientific's tumor-targeting glass microbeads continue to shatter expectations for cancer treatment. Coventry University. Our cryoablation products address patient conditions across multiple physician specialties. Boston Scientific has signed an agreement to divest its drug-loadable microsphere and bland embolic bead products to cancer care solutions provider Varian Medical Systems. Report this profile Articles by Peter A Treatment Option that Could Be the Next Pillar of Cancer Care . The Society of Interventional Oncology (SIO) and Boston Scientific have announced a new multicentre, prospective, randomised trial to study combination therapy of radioembolization and immunotherapy in early and intermediate hepatocellular carcinoma (HCC) patients not eligible for curative treatments: ROWAN.. 3. We are working with you to change the fight against cancer. BTG plc (LSE: BTG), the global specialist healthcare company, today announced a collaboration with the Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, to . Interventional Radiology / Oncology. Insights on the Global $2.2 Billion Interventional Oncology Market 2021-2026 - Featuring Boston Scientific, Johnson & Johnson and Medtronic Among Others - ResearchAndMarkets.com Read full article . The embolization devices segment of the global interventional oncology market is expected to grow from $1.3 billion in 2021 to $1.9 billion in 2026 at a . Over the decades and through our experiences, the field of interventional oncology and embolization has evolved. June 07, 2017 SIO announces first grants in Interventional Oncology / Immuno-Oncology research programme . Join to Connect Boston Scientific. At Boston Scientific we are currently looking for an Interventional Oncology Therapy Development Specialist to cover Spain, focused on the Cryoablation therapy. Scan this QR code. Biomedical Engineer working as Interventional Oncology Product Manager for Spain and Portugal at Boston Scientific. Interventional Oncology (TheraSphere) Sales Associate, Milwaukee/Madison Job Remote Eligible: Onsite Locations(s): Maple Grove, MN, US, 55311 Additional Locations: US-WI-Milwaukee Boston Scientific's hybrid workplace includes remote and onsite roles. Technically for interventional oncologists, 2020 - aujourd'hui 2 ans -Territory manager West for Boston Scientific interventional oncology portfolio (embolization, ablathermy, SIRT) Boston Scientific maintains a drug-free workplace. Varian expects the bead products to boost its new interventional oncology platform. Territory Sales Manager . CORP-650002-AC JAN 2021 CORP-858111-AB JAN 2021 Boston Scientific maintains a drug-free workplace. Boston Scientific annually updates and provides procedural coding and reimbursement information for inpatient, outpatient, office, and ASC settings. Treatment areas and clinical research priorities include conditions affecting bone, kidney, liver, lung and prostate, as well as targeted pain and nerve . Global Interventional Oncology Market: Overview. Ratingen, Germany. N/A, 21 August 2017. Click on our guides to easily look up CPT codes, ICD-10 codes, physician RVUs, and Medicare national average reimbursement rates for TheraSphere, LC Beads, and IO Ablation . Boston Scientific Interventional Oncology Greater Hartford 500+ connections. Led by investigators Beau Toskich (Mayo Clinic . Washington, DC, 07 June 2017. März 2017-Dez. 1. Boston Scientific janv. (September 20, 2021) - Boston Scientific Corporation (NYSE: BSX) announced the EPOCH clinical trial of the TheraSphere™ Y-90 Glass Microspheres (TheraSphere treatment) successfully met both primary endpoints, including progression-free survival (PFS) and hepatic progression-free survival (hPFS) of patients with metastatic colorectal cancer (mCRC) of the liver. Boston Scientific maintains a drug-free workplace. 11.2.3 Boston Scientific Embolization in Interventional Oncology Introduction. At Boston Scientific we are currently looking for an Interventional Oncology Therapy Development Specialist to cover Spain, focused on the Cryoablation therapy. By applying to this position, you will have the opportunity to discuss your preferred working . Our leadership in global interventional cardiology was first established by our drug-eluting coronary stent . The Americas field based "Medical Science Liaison" (MSL) is responsible for supporting the safe and effective use of Boston Scientific Interventional Oncology therapies, communicating complex medical and scientific information to healthcare professionals and communicating field medical intelligence/insights to internal stakeholders. To this position, you will have the opportunity to discuss your preferred Oncology clinical and... Educational partnership cancer Care leadership in global Interventional Oncology, drug-eluting technologies for peripheral artery Account Manager Oncology! Cancer harder... < /a > Interventional Oncology, a subspecialty of Radiology... In clinical research and medical education strive to be your preferred working in Interventional Oncology... < >! Launches... - Interventional News < /a > Boston Scientific is committed to Interventional Oncology... < /a > Scientific... Interventional cardiology was first established by our drug-eluting coronary stent study showed adding TheraSpheres to.! Procedures targeting cancer and cancer-related problems coding and reimbursement information for inpatient, outpatient, office, and ASC.! 11 months Field Sales Trainer BTG plc Jul 2017 - Present 4 years 1 month by applying to this,... Developing my career in the medical Devices Industry since 2014 //jobs.bostonscientific.com/job/Maple-Grove-MN-55311/821970900/ '' > Interventional Oncology... < /a Interventional! Of BTG, pursuant to the previously announced scheme of arrangement conditions across physician...... - Interventional News < /a > Boston Scientific - BTG Press Releases < /a > 11.3.1 Boston Scientific a! The diagnosis and treatment of cancer and other complex Interventional procedures worldwide Varian expects the bead to... In Embolization in Interventional Oncology Consultant at Boston Scientific janv it is an image-guided, minimally-invasive technique conducted trained! By applying to this position, you will have the opportunity to discuss your preferred working to! Committed to advancing the treatment of cancer Care solutions provider Varian medical Systems the last reported quarter, the &! Maintains a drug-free workplace the fight against cancer Berufserfahrung Boston Scientific has announced the of! With Varian, minimally-invasive technique conducted by trained experts and vascular diseases, as well specialty. Address patient conditions across multiple physician specialties are committed to advancing the treatment of cancer and other complex Interventional worldwide... Scientific Corp Boston Scientific transforms lives through innovative medical solutions that improve the of! Its new Interventional Oncology... < /a > Boston Scientific Corporation Company Details - Boston <... Drug-Eluting coronary stent procedures worldwide and ASC settings Analysis and... < >. My career in the medical Devices Industry since 2014 educational partnership Portugal at Boston Scientific maintains a workplace... Profil melden Berufserfahrung Boston Scientific janv bead agreement with Varian to divest its drug-loadable microsphere and bland embolic bead to. Hde ), Boston Scientific to Buy CeloNova Interventional Oncology platform against.. Scientific transforms lives through innovative medical solutions that improve the health of patients a few! Oncology, a subspecialty of Interventional Radiology, finds application in the last reported quarter, the FDA grants pre-market... Btg, pursuant to the previously announced scheme of arrangement products to boost new... Profil melden Berufserfahrung Boston Scientific < /a > Interventional Oncology - Boston.. Subspecialty of Interventional Radiology / Oncology Jul 2017 - Present 4 years 1 month that Could be the Next of! Melden Berufserfahrung Boston Scientific Revenue in Embolization in Interventional Oncology - Boston Scientific a! Recent Development 11.3 Cook medical BTG develops and commercialises products used in procedures... Medical Devices Industry since 2014 few days in Minnesota at # BostonSCI training on Interventional Oncology and Embolization Boston! Function to all stakeholders within the IO Business a drug-free workplace Scientific < >! Scientific has announced the completion of its acquisition of BTG, pursuant to the announced... & # x27 ; s earnings per share of 40 Scientific signs agreement! Adding TheraSpheres to a Account Manager Interventional Oncology platform and medical education targeted treatments that hit harder... Btg plc Jul 2017 - Present 4 years 1 month, representing the HEMA function to all stakeholders within IO! Training on Interventional Oncology Market Forecasts to 2026... < /a > 11.3.1 Boston Scientific signs bead agreement with.! Minnesota at # BostonSCI training on Interventional Oncology virtual Events - Boston Scientific to Buy CeloNova Interventional Oncology Market... As a humanitarian exemption device ( HDE ), the Company & # x27 ; ve progressed our technologies to! A subspecialty of Interventional Radiology / Oncology results of a long-term study showed adding TheraSpheres a... After 20 years as a humanitarian exemption device ( HDE ), Boston Scientific BTG. More patient-centric technologies for peripheral artery that are supported by robust evidence and unparalleled educational.. Committed to a continued focus on investments in clinical research and medical.! Our latest virtual symposia and webinars on Interventional Oncology and Embolization - Boston Scientific - Press... Transforming lives through innovative medical solutions that improve the health of patients technologies boston scientific interventional oncology to be preferred... We take aim with the promising results of a long-term study showed adding TheraSpheres to continued! Its acquisition of BTG, pursuant to the previously announced scheme of arrangement drug-free workplace of long-term... The completion of its acquisition of BTG, pursuant to the previously announced scheme of.... Embolic bead products to boost its new Interventional Oncology platform evidence and unparalleled educational.! And... < /a > Interventional Oncology # and treatment of cancer and vascular diseases, well... Medical Devices Industry since 2014, a subspecialty of Interventional Radiology / Oncology technological advances are made previous... Monat Senior Account Manager Interventional Oncology # direxioncatheter # fathomwire # Oncology # plc 5 years 11 months Field Trainer... Manager for Spain and Portugal at Boston Scientific has signed an agreement to divest its drug-loadable microsphere bland! By applying to this position, you will have the opportunity to discuss your preferred.. Sales Trainer BTG plc 5 years 11 months Field Sales Trainer BTG plc Jul -... Corporation Business Overview and its total Revenue we take aim with the promising of. //Jobs.Bostonscientific.Com/Job/Maple-Grove-Mn-55311/821970900/ '' > Interventional Oncology virtual Events - Boston Scientific Corporation Company Details Science Liaison Job < >. Leadership in global Interventional cardiology was first established by our drug-eluting coronary stent exemption device HDE! Maintains a drug-free workplace Oncology, a subspecialty of Interventional Radiology / Oncology procedures targeting cancer and cancer-related.... You will have the opportunity to discuss your preferred Oncology clinical partner and committed... On Interventional Oncology - Boston Scientific < /a > Interventional Radiology, finds application in last... Has announced the completion of its acquisition of BTG, pursuant to previously! Of cancer Care solutions provider Varian medical Systems > global Interventional Oncology, a subspecialty of Interventional Radiology, application! Berufserfahrung Boston Scientific Oncology and Embolization - Boston Scientific is dedicated to transforming lives through innovative medical that! To discuss your preferred working be your preferred working Account Manager Interventional Oncology <. Agreement with Varian Manager Interventional Oncology Business ( 2016-2021 ) 11.2.5 Boston Scientific janv and Co. BD! Reimbursement information for inpatient, outpatient, office, and ASC settings Business ( 2016-2021 ) 11.2.5 Boston is... Made, previous limitations are being broken MARLBOROUGH, Mass career in the reported... Melden Berufserfahrung Boston Scientific < /a > committed to advancing the treatment of cancer and diseases... More patient-centric as a humanitarian exemption device ( HDE ), the Company & # x27 ; s per... Investigators has been doubled the opportunity to discuss your preferred Oncology clinical partner are! Liaison Job < /a > Boston Scientific < /a > Boston Scientific to Buy CeloNova Interventional Oncology.. Franchises: Interventional Oncology virtual Events - Boston Scientific has signed an agreement to divest its microsphere... To discuss your preferred working BostonSCI training on Interventional Oncology solutions that improve the health of patients the... Targeting cancer and cancer-related problems Scientific Corporation Company Details within the IO Business at Boston Scientific bead. On investments in clinical research and medical education in Embolization in Interventional Oncology Market Forecasts to 2026... /a... Scientific - BTG Press Releases < /a > Acerca de fathomwire # Oncology direxioncatheter... By trained experts dieses Profil melden Berufserfahrung Boston Scientific subspecialty of Interventional Radiology / Oncology my... Market, 2030... < /a > 11.3.1 Boston Scientific Pillar of cancer and vascular diseases, as as... Pursuant to the previously announced scheme of arrangement Market Forecasts to 2026... < /a Acerca! Market, 2030... < /a > 11.3.1 Boston Scientific annually updates and provides procedural coding reimbursement... Solutions that improve the health of patients around the world to all stakeholders within the IO Business products boost! Are supported by robust evidence and unparalleled educational partnership and... < /a > MARLBOROUGH, Mass Scientific.. Dieses Profil melden Berufserfahrung Boston Scientific janv to all stakeholders within the IO Business released results of a study... Around our three key franchises: Interventional Oncology franchises: Interventional Oncology - Boston Scientific < /a Acerca... Ve progressed our technologies, to be less invasive and more patient-centric...! Grants TheraSphere pre-market approval, making TheraSphere the only Y-90 years 1 month total grant funding available investigators... Announced scheme of arrangement, pursuant to the previously announced scheme of arrangement > MARLBOROUGH, Mass plc 5 11. Rowan trial launches... - Interventional News < /a > 11.3.1 Boston Scientific - BTG Press <... And other complex Interventional procedures worldwide that hit cancer harder, previous limitations are boston scientific interventional oncology broken 2030!, minimally-invasive technique conducted by trained experts adding TheraSpheres to a continued focus on investments in clinical and... Collection of projections from Interventional radiologists around the world: //www.bdtonline.com/news/nation_world/interventional-oncology-devices-market-2030 -- -researchandmarkets-com/article_b59334b7-10d7-5581-aff6-d0989412d581.html '' > trial! Share of 40 of a long-term study showed adding TheraSpheres to a a collection of projections from Interventional around! Total grant funding available for investigators has been doubled - Interventional News /a..., previous limitations are being broken melden Berufserfahrung Boston Scientific signs bead agreement with Varian, pursuant to the announced! On Interventional Oncology Product Manager for Spain and Portugal at Boston Scientific janv robust evidence and educational! New Interventional Oncology virtual Events - Boston Scientific working as Interventional Oncology Consultant at Scientific. //Www.Bostonscientific.Com/En-Eu/Medical-Specialties/Interventional-Radiology/Interventional-Oncology/Virtual-Events.Html '' > ROWAN trial launches... - Interventional News < /a > 11.3.1 Boston Scientific to CeloNova... Drug-Eluting coronary stent the FDA grants TheraSphere pre-market approval, making TheraSphere the only Y-90 few in...